Lee Boram, Kwon Chan-Young, Jeong Yoon Kyoung, Ha Na-Yeon, Kim Kwan-Il, Lee Beom-Joon, Lee Jun-Hwan
KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.
Department of Oriental Neuropsychiatry, Dong-eui University College of Korean Medicine, Busan, Republic of Korea.
Integr Med Res. 2025 Mar;14(1):101121. doi: 10.1016/j.imr.2025.101121. Epub 2025 Jan 2.
Despite the high prevalence and socioeconomic burden of chronic cough, there has been an unmet medical need. Acupuncture may be promising for treating chronic cough with various pathophysiologies involving several neurotransmission mechanisms. We aimed to systematically compile evidence on the effect and safety of acupuncture-related therapy for chronic cough.
Through a search of 11 databases, randomized controlled trials (RCTs) published until February 15, 2024 that evaluated the effect of acupuncture-related therapy at acupuncture points (including acupuncture, acupoint herbal patching, and moxibustion) for patients with chronic cough were identified and analyzed without restrictions on the cause of cough or age. When there were two or more studies that measured the same outcome measures, a meta-analysis was performed, and the certainty of evidence was evaluated based on the GRADE methodology.
A total of 30 RCTs with 2835 participants were included. When acupuncture-related therapy was implemented in addition to conventional treatment including medicine and lifestyle guidance according to symptoms and causes, cough severity, cough-related quality of life, and the total effective rate (TER) were significantly improved with no difference in the incidence of adverse events. Furthermore, compared with conventional treatment, acupuncture-related therapy significantly improved cough severity and the TER. The certainty of the evidence was generally moderate due to the risk of bias. The most frequently used acupuncture points in the included studies were BL13, GV14, CV17, and EX-B1.
Acupuncture-related therapy might be an effective and safe treatment for patients with chronic cough of various causes with complex pathophysiologies.
PROSPERO, CRD42024518115. PROSPERO (CRD42024518115).
尽管慢性咳嗽的患病率很高且具有社会经济负担,但仍存在未满足的医疗需求。针灸对于治疗涉及多种神经传递机制的各种病理生理学的慢性咳嗽可能具有前景。我们旨在系统地收集有关针灸相关疗法治疗慢性咳嗽的疗效和安全性的证据。
通过检索11个数据库,识别并分析截至2024年2月15日发表的随机对照试验(RCT),这些试验评估了针对慢性咳嗽患者在穴位进行针灸相关疗法(包括针刺、穴位贴敷和艾灸)的效果,对咳嗽原因或年龄没有限制。当有两项或更多研究测量相同的结局指标时,进行荟萃分析,并根据GRADE方法评估证据的确定性。
共纳入30项RCT,涉及2835名参与者。当在根据症状和病因进行的包括药物和生活方式指导在内的常规治疗基础上实施针灸相关疗法时,咳嗽严重程度、咳嗽相关生活质量和总有效率(TER)显著改善,不良事件发生率无差异。此外,与常规治疗相比,针灸相关疗法显著改善了咳嗽严重程度和TER。由于存在偏倚风险,证据的确定性一般为中等。纳入研究中最常用的穴位是BL13、GV14、CV17和EX - B1。
针灸相关疗法可能是治疗各种病因、病理生理学复杂的慢性咳嗽患者的一种有效且安全的治疗方法。
PROSPERO,CRD42024518115。PROSPERO(CRD42024518115)。